PepsiCo appoints Chief Medical Officer
Pietro Antonio Tataranni, MD, has been named PepsiCo’s global Chief Medical Officer.
Dr. Tataranni will continue to oversee all aspects of the company's efforts to protect its global workforce, products and communities in the face of the COVID-19 pandemic. He will also continue to lead PepsiCo's Life Sciences strategy and the R&D Fellows Program as its Executive Sponsor, reporting to René Lammers, EVP & Chief Science Officer.
Having joined PepsiCo in September 2018, Dr. Tataranni has served as Deputy Chief Scientific Officer and Senior Vice President of Life Sciences where he drives the company's Nutrition Sciences, Sports Science and External Innovation strategies, looking at science around physiology, diet and health to guide innovation and portfolio transformation.
He also leads PepsiCo's scientific research agenda to build recommendations and a future roadmap to enable innovations in line with PepsiCo's "Winning with Purpose" agenda.
Prior to joining PepsiCo, Dr. Tataranni worked for pharmaceutical giant Sanofi as a Senior Vice President and Head of Medical Affairs for the Diabetes and Cardiovascular Business Unit. Before Sanofi, he worked as a clinician, scientist, and physician at organizations including Merck and the National Institute of Health (NIH).